The stock of Apollo Hospitals Enterprise (AHEL), India's largest listed health care services company, fell 4.6 per cent on Monday and slipped another 0.34 per cent to close at ₹5,946.20 on Tuesday. The share declined due to a lower valuation for subsidiary Apollo HealthCo (AHL) and an aggressive valuation for Keimed, a promoter-owned drug wholesaler that is merging with AHL.
AHEL, in a two-step process, is selling a partial stake in AHL and merging Keimed with AHL, a digital healthcare and omnichannel pharmacy.
While views on Keimed vary, most brokerages have pegged higher valuations for AHL.
AHEL is raising equity capital of 2,475 crore from Advent International in two tranches to give the global private equity investor a 16.8 per cent stake in AHL.
The money raised will be used for growth capital in AHL, pay ₹890 crore of the 1,290 crore slump sale consideration owed to AHEL, and to acquire an 11.2 per cent stake in Keimed for 730 crore.
هذه القصة مأخوذة من طبعة May 02, 2024 من Business Standard.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 8500 مجلة وصحيفة.
بالفعل مشترك ? تسجيل الدخول
هذه القصة مأخوذة من طبعة May 02, 2024 من Business Standard.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 8500 مجلة وصحيفة.
بالفعل مشترك? تسجيل الدخول
Chennai In Wait-And-Watch Mode: Will CSK Paint The Town Yellow?
Come Saturday, hundreds and thousands of Chennai's 6.6 million people, and millions of fans outside the city, will be rooting for Chennai Super Kings (CSK) as they clash against Royal Challengers Bangalore (RCB).
Financial Markets Prefer Stability, Predictability: FM
Warns of unchecked explosion in F&O retail trades
I Never Do Hindu-Muslim Politics: Modi
Celebrated Eid; Oppn tarnished image among Muslims after 2002: PM
India's Al Spend May Touch $5 bn By 2027
Spending on artificial intelligence (AI) in India is expected to grow at a compound annual growth rate of 31.5 per cent from 2023 and might reach $5.1 billion by 2027, according to a joint study released on Tuesday by Intel and International Data Corporation (IDC).
Multiple launches to boost Cipla's margin prescription
The shares of pharma major Cipla slipped by about 4 per cent on Tuesday, after gaining over 5.6 per cent a day earlier.
Novelis files papers in US for IPO
Novelis, Hindalco Industries' US subsidiary, has filed a registration statement on Form F1 for its proposed initial public offering (IPO) with US securities regulator Securities and Exchange Commission (SEC), the firm said.
MF investment strategy: Be wary of rich valuations
Mutual fund investors are in the crosshairs due to the widespread offloading of stocks by foreign institutional investors (FIIs), expensive valuations of the Indian markets compared to global peers, and nervousness ahead of the Lok Sabha election results.
MFS EMBRACE HEALTHCARE, FINANCE STOCKS AS SMALLCAPS BOUNCE BACK
Mutual funds (MFS) embraced smallcap shares across sectors like healthcare, hospitality, and financial services, as the net inflows bounced back in April from the March lows.
JSPL stock factoring in improving prospects
THE COMPASS DEVANGSHU DATTA Jindal Steel & Power's (JSPL's) Q4FY24 results were in line with consensus.
Ease penal action for glitches, Mils appeal to Sebi
Regulator to seek suggestions applicability of financial disincentives